Human Beta-Defensin-1, -2, and -3 Exhibit Opposite Effects on Oral Squamous Cell Carcinoma Cell Proliferation

REFERENCES

• Silverman, S. Jr. Oral Cancer, 4th edition. Hamilton: B.C. Decker, 1998, 25–33.
   Google Scholar
• Chambers MS, Jacob RF. How carcinogens cause cancer. Tex Dent J 1994;111:13–19.
   Google Scholar
• Wenghoefer M, Pesch B, Harth V, Broede P, Fronhoffs S, Landt O, Brüning, T, Abel J, Bolt HM, Herberhold C, Vetter H, Ko YD. Association between head and neck cancer and microsomal epoxide hydrolase genotypes. Arch Toxicol 2003;77(1):37–41.
   PubMed Web of Science ®Google Scholar
• Pindborg JJ. Oral Cancer and Precancer. Bristol: John Wright and Sons, Ltd., 1980.
   Google Scholar
• Shintani S, Mihara M, Nakahara Y, Kiyota A, Ueyama Y, Matsumura T, Wong DT. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol 2002;38(3):235–243.
   PubMed Web of Science ®Google Scholar
• Bouquot JE. Epidemiology. In Pathology of the Head and Neck, D.G. Gnepp (ed.). New York: Churchill Livingstone, 1987; 263–314.
   Google Scholar
• Bouquot JE. Reviewing oral leukoplakia-clinical concepts for the 1990s. J Amer Dent Assoc 1991;122:80–82.
   PubMed Web of Science ®Google Scholar
• Wenghoefer M, Pantelis A, Dommisch H, Reich R, Martini M, Allam JP, Novak N, Bergé, S, Jepsen S, Winter J. Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg 2008;37(7):660–663.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. SEER Brochure 2005. Bethesda, MD: Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute, 2005. Available from: www.cancer.gov.
   Google Scholar
• Wenghoefer M, Pantelis A, Dommisch H, Götz, W, Reich R, Bergé, S, Martini M, Allam JP, Jepsen S, Merkelbach-Bruse, S, Fischer HP, Novak N, Winter J. Nuclear hBD-1 accumulation in malignant salivary gland tumours. BMC Cancer 2008;7:8, 290.
   Google Scholar
• Wenghoefer M, Pantelis A, Najafi T, Deschner J, Allam JP, Novak N, Reich RH, Martini M, Bergé, S, Jepsen S, Winter J. Gene expression of oncogenes, antimicrobial peptides and cytokines in the development of oral leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110(3):351–356.
   PubMed Web of Science ®Google Scholar
• Pantelis A, Wenghoefer M, Haas S, Merkelbach-Bruse, S, Pantelis D, Jepsen S, Bootz F, Winter J. Down regulation and nuclear localization of human beta-defensin-1 in pleomorphic adenomas of salivary glands. Oral Oncol 2009;45(6):526–530.
   PubMed Web of Science ®Google Scholar
• Kesting MR, Loeffelbein DJ, Hasler RJ, Wolff KD, Rittig A, Schulte M, Hirsch T, Wagenpfeil S, Jacobsen F, Steinstraesser L. Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. Cancer Invest 2009;27(5):575–581.
   PubMed Web of Science ®Google Scholar
• Dommisch H, Acil Y, Dunsche A, Winter J, Jepsen S. Differential gene expression of human beta-defensins (hBD-1, -2, -3) in inflammatory gingival diseases. Oral Microbiol Immunol 2005;20(3):186–190.
   PubMedGoogle Scholar
• Dommisch H, Winter J, Willebrand C, Eberhard J, Jepsen S. Immune regulatory functions of human beta-defensin-2 in odontoblast-like cells. Int Endod J 2007;40(4):300–307.
   PubMed Web of Science ®Google Scholar
• Dunsche A, Acil Y, Dommisch H, Siebert R, Schroder JM, Jepsen S. The novel human beta-defensin-3 is widely expressed in oral tissues. Eur J Oral Sci 2002;110(2):121–124.
   PubMed Web of Science ®Google Scholar
• Donald CD, Sun CQ, Lim SD, Macoska J, Cohen C, Amin MB, Young AN, Ganz TA, Marshall FF, Petros JA. Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Lab Invest 2003;83(4):501–505.
   PubMed Web of Science ®Google Scholar
• Sun CQ, Arnold R, Fernandez-Golarz, C, Parrish AB, Almekinder T, He J, Ho SM, Svoboda P, Pohl J, Marshall FF, Petros JA. Human {beta}-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res 2006;66(17):8542–8549.
   PubMed Web of Science ®Google Scholar
• Joly S, Compton LM, Pujol C, Kurago ZB, Guthmiller JM. Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiol Immunol 2009;24:353–360.
   PubMedGoogle Scholar
• Yoshimoto T, Yamaai T, Mizukawa N, Sawaki K, Nakano M, Yamachika E, Sugahara T. Different expression patterns of beta-defensins in human squamous cell carcinomas. Anticancer Res 2003;23:4629–4633.
   PubMed Web of Science ®Google Scholar
• Mizukawa N, Sawaki K, Yamachika E, Fukunaga J, Ueno T, Takagi S, Sugahara T. Presence of human beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 2000;20:2005–2007.
   PubMed Web of Science ®Google Scholar
• Sawaki K, Mizukawa N, Yamaai T, Yoshimoto T, Nakano M, Sugahara T. High concentration of beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 2002;22:2103–2107.
   PubMed Web of Science ®Google Scholar
• Nishimura M, Abiko Y, Kurashige Y, Takeshima M, Yamazaki M, Kusano K, Saitoh M, Nakashima K, Inoue T, Kaku T. Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines. J Dermatol Sci 2004;26:87–95.
   Google Scholar
• Mathews M, Jia HP, Guthmiller JM, Losh G, Graham S, Johnson GK, Tack BF, McCray, PB, Jr. Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun 1999;67(6):2740–2745.
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:2002–2007.
   Web of Science ®Google Scholar
• Kwasar HI, Ghosh SK, Hirsch SA, Koon HB, Weinberg A, Jin G. Expression of human beta-defensin-2 in intratumoral vascular endothelium and in endothelial cells induced by transforming growth factor beta. Peptides 2010;31:195–201.
   PubMed Web of Science ®Google Scholar
• Abiko Y, Mitamura J, Nishimura M, Muramatsu T, Inoue T, Shimono M, Kaku T. Pattern of expression of beta-defensins in oral squamous cell carcinoma. Cancer Lett 1999;143:37–43.
   PubMed Web of Science ®Google Scholar